Search / Trial NCT06236776

AWARE Registry: Wearable ECG in Structural Heart Interventions

Launched by YONSEI UNIVERSITY · Jan 24, 2024

Trial Information

Current as of October 03, 2024

Not yet recruiting

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Adult ≥ 19 year-old
  • * Patients who scheduled to perform percutaneous device closure for atrial septal defect or patent foramen ovale
  • * Patients provided with the written, informed consent to participate in this study
  • Exclusion Criteria:
  • * Patients who had paroxysmal, persistent, or chronic AF
  • * Life expectancy \< 12 months
  • * Subject who the investigator deems inappropriate to participate in this study

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Seoul, , Korea, Republic Of

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0